Sarepta Therapeutics, Inc. (SRPT)
21.55
+0.38
(+1.80%)
USD |
NASDAQ |
Apr 17, 16:00
21.55
0.00 (0.00%)
After-Hours: 20:00
Sarepta Therapeutics SG&A Expense (Quarterly) : 128.30M for Dec. 31, 2025
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 11.74M |
| Merck & Co., Inc. | 2.898B |
| PTC Therapeutics, Inc. | 96.87M |
| REGENXBIO, Inc. | 22.38M |
| Gilead Sciences, Inc. | 4.418B |